1. Nephrotic syndrome as a complication of chronic graft‐versus‐host disease after allogeneic haemopoietic stem cell transplantation. Issue 6 (3rd June 2016) Authors: Wong, E.; Lasica, M.; He, S. Z.; Bajel, A.; Roberts, A. W.; Mason, K. D.; Ritchie, D. S.; Szer, J. Journal: Internal medicine journal Issue: Volume 46:Issue 6(2016) Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P687: A PHASE 1 STUDY WITH THE NOVEL B-CELL LYMPHOMA 2 (BCL2) INHIBITOR BGB-11417 AS MONOTHERAPY OR IN COMBINATION WITH ZANUBRUTINIB (ZANU) IN PATIENTS (PTS) WITH B-CELL MALIGNANCIES: PRELIMINARY DATA. (23rd June 2022) Authors: Opat, S.; Cheah, C. Y.; Lasica, M.; Verner, E.; Browett, P. J.; Chan, H.; Soumerai, J. D.; González Barca, E.; Hilger, J.; Fang, Y.; Huang, J.; Simpson, D.; Tam, C. S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY. (23rd June 2022) Authors: Lasica, M.; Spencer, A.; Campbell, P.; Wallington-Gates, C.; Wong Doo, N.; Janowski, W.; McCaughan, G.; Puliyayil, A.; Yuen, F.; Le, K.; Reynolds, J.; Quach, H. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 836 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗